These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 31293655)

  • 41. MiR-122 inhibits epithelial-mesenchymal transition in hepatocellular carcinoma by targeting Snail1 and Snail2 and suppressing WNT/β-cadherin signaling pathway.
    Jin Y; Wang J; Han J; Luo D; Sun Z
    Exp Cell Res; 2017 Nov; 360(2):210-217. PubMed ID: 28890291
    [TBL] [Abstract][Full Text] [Related]  

  • 42. STAT3 cooperates with Twist to mediate epithelial-mesenchymal transition in human hepatocellular carcinoma cells.
    Zhang C; Guo F; Xu G; Ma J; Shao F
    Oncol Rep; 2015 Apr; 33(4):1872-82. PubMed ID: 25653024
    [TBL] [Abstract][Full Text] [Related]  

  • 43. EDIL3 is a novel regulator of epithelial-mesenchymal transition controlling early recurrence of hepatocellular carcinoma.
    Xia H; Chen J; Shi M; Gao H; Sekar K; Seshachalam VP; Ooi LL; Hui KM
    J Hepatol; 2015 Oct; 63(4):863-73. PubMed ID: 25980764
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MiR-542-3p inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting UBE3C.
    Tao J; Liu Z; Wang Y; Wang L; Yao B; Li Q; Wang C; Tu K; Liu Q
    Biomed Pharmacother; 2017 Sep; 93():420-428. PubMed ID: 28666208
    [TBL] [Abstract][Full Text] [Related]  

  • 45. FoxM1 promotes epithelial-mesenchymal transition, invasion, and migration of tongue squamous cell carcinoma cells through a c-Met/AKT-dependent positive feedback loop.
    Yang H; Wen L; Wen M; Liu T; Zhao L; Wu B; Yun Y; Liu W; Wang H; Wang Y; Wen N
    Anticancer Drugs; 2018 Mar; 29(3):216-226. PubMed ID: 29360662
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Long non-coding RNA AOC4P suppresses hepatocellular carcinoma metastasis by enhancing vimentin degradation and inhibiting epithelial-mesenchymal transition.
    Wang TH; Lin YS; Chen Y; Yeh CT; Huang YL; Hsieh TH; Shieh TM; Hsueh C; Chen TC
    Oncotarget; 2015 Sep; 6(27):23342-57. PubMed ID: 26160837
    [TBL] [Abstract][Full Text] [Related]  

  • 47. PHF8 upregulation contributes to autophagic degradation of E-cadherin, epithelial-mesenchymal transition and metastasis in hepatocellular carcinoma.
    Zhou W; Gong L; Wu Q; Xing C; Wei B; Chen T; Zhou Y; Yin S; Jiang B; Xie H; Zhou L; Zheng S
    J Exp Clin Cancer Res; 2018 Sep; 37(1):215. PubMed ID: 30180906
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long non-coding RNA CCAT2 is associated with poor prognosis in hepatocellular carcinoma and promotes tumor metastasis by regulating Snail2-mediated epithelial-mesenchymal transition.
    Xu Y; Wang B; Zhang F; Wang A; Du X; Hu P; Zhu Y; Fang Z
    Onco Targets Ther; 2017; 10():1191-1198. PubMed ID: 28280353
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Autophagy promotes hepatocellular carcinoma cell invasion through activation of epithelial-mesenchymal transition.
    Li J; Yang B; Zhou Q; Wu Y; Shang D; Guo Y; Song Z; Zheng Q; Xiong J
    Carcinogenesis; 2013 Jun; 34(6):1343-51. PubMed ID: 23430956
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Methylation-associated silencing of microRNA-129-3p promotes epithelial-mesenchymal transition, invasion and metastasis of hepatocelluar cancer by targeting Aurora-A.
    Cui S; Zhang K; Li C; Chen J; Pan Y; Feng B; Lu L; Zhu Z; Wang R; Chen L
    Oncotarget; 2016 Nov; 7(47):78009-78028. PubMed ID: 27793005
    [TBL] [Abstract][Full Text] [Related]  

  • 51. C5a receptor enhances hepatocellular carcinoma cell invasiveness via activating ERK1/2-mediated epithelial-mesenchymal transition.
    Hu WH; Hu Z; Shen X; Dong LY; Zhou WZ; Yu XX
    Exp Mol Pathol; 2016 Feb; 100(1):101-8. PubMed ID: 26475622
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ubiquitin-specific protease 4 promotes metastasis of hepatocellular carcinoma by increasing TGF-β signaling-induced epithelial-mesenchymal transition.
    Qiu C; Liu Y; Mei Y; Zou M; Zhao Z; Ye M; Wu X
    Aging (Albany NY); 2018 Oct; 10(10):2783-2799. PubMed ID: 30335615
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Identification of Crucial Genes Associated With Immune Cell Infiltration in Hepatocellular Carcinoma by Weighted Gene Co-expression Network Analysis.
    Wang D; Liu J; Liu S; Li W
    Front Genet; 2020; 11():342. PubMed ID: 32391055
    [TBL] [Abstract][Full Text] [Related]  

  • 54. miR-300 regulates the epithelial-mesenchymal transition and invasion of hepatocellular carcinoma by targeting the FAK/PI3K/AKT signaling pathway.
    Wang R; Yu Z; Chen F; Xu H; Shen S; Chen W; Chen L; Su Q; Zhang L; Bi J; Zeng W; Li W; Huang X; Wang Q
    Biomed Pharmacother; 2018 Jul; 103():1632-1642. PubMed ID: 29864952
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Role of LncRNAs in the Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma.
    Ge X; Yao Y; Li J; Li Z; Han X
    Front Oncol; 2021; 11():690800. PubMed ID: 34113574
    [TBL] [Abstract][Full Text] [Related]  

  • 56. MYC associated zinc finger protein promotes the invasion and metastasis of hepatocellular carcinoma by inducing epithelial mesenchymal transition.
    Luo W; Zhu X; Liu W; Ren Y; Bei C; Qin L; Miao X; Tang F; Tang G; Tan S
    Oncotarget; 2016 Dec; 7(52):86420-86432. PubMed ID: 27861158
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Transcription factor FOXM1 promotes hepatocellular carcinoma malignant progression through activation of the WNT pathway by binding to SETDB1.
    Kong J; Xu S; Deng Z; Wang Y; Zhang P
    Tissue Cell; 2023 Oct; 84():102186. PubMed ID: 37556918
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Expression of Ovol2 is related to epithelial characteristics and shows a favorable clinical outcome in hepatocellular carcinoma.
    Fu H; Qi L; Chen L; He Y; Zhang N; Guo H
    Onco Targets Ther; 2016; 9():5963-5973. PubMed ID: 27729805
    [TBL] [Abstract][Full Text] [Related]  

  • 59. MCUR1 facilitates epithelial-mesenchymal transition and metastasis via the mitochondrial calcium dependent ROS/Nrf2/Notch pathway in hepatocellular carcinoma.
    Jin M; Wang J; Ji X; Cao H; Zhu J; Chen Y; Yang J; Zhao Z; Ren T; Xing J
    J Exp Clin Cancer Res; 2019 Mar; 38(1):136. PubMed ID: 30909929
    [TBL] [Abstract][Full Text] [Related]  

  • 60. POU2F1 over-expression correlates with poor prognoses and promotes cell growth and epithelial-to-mesenchymal transition in hepatocellular carcinoma.
    Zhong Y; Huang H; Chen M; Huang J; Wu Q; Yan GR; Chen D
    Oncotarget; 2017 Jul; 8(27):44082-44095. PubMed ID: 28489585
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.